efficacy and tolerability of candesartan cilexetil and amlodipine in patients with poorly controlled essential hypertension坎地沙坦的疗效和耐受性cilexetil和氨氯地平差控制的原发性高血压患者.pdfVIP

efficacy and tolerability of candesartan cilexetil and amlodipine in patients with poorly controlled essential hypertension坎地沙坦的疗效和耐受性cilexetil和氨氯地平差控制的原发性高血压患者.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
efficacy and tolerability of candesartan cilexetil and amlodipine in patients with poorly controlled essential hypertension坎地沙坦的疗效和耐受性cilexetil和氨氯地平差控制的原发性高血压患者

International Journal of Clinical Medicine, 2011, 2, 64-68 doi:10.4236/ijcm.2011.22012 Published Online May 2011 (http://www.SciRP.org/journal/ijcm) Efficacy and Tolerability of Candesartan Cilexetil and Amlodipine in Patients with Poorly Controlled Essential Hypertension —Efficacy of Candesartan and Amlodipine Kazuaki Nishio, Takeshi Kondo, Youichi Kobayashi The Third Department of Internal Medicine, School of Medicine, Showa University, Tokyo, Japan. Email: kazukun@jg7.so-net.ne.jp Received August 13th, 2010; revised January 7th, 2011; accepted January 15th, 2011. ABSTRACT Current treatment guidelines for hypertension in both Europe and the USA stress the importance of aggressive blood pressure control . When monotherapy is not enough to reach treatment targets, there is a need for combination regimens that have both high efficacy and good tolerability. The aim of this study is to evaluate the efficacy and tolerability of the combination therapy candesartan and amlodipine in patients with hypertension not satisfactorily controlled by mono- therapy. Patients with uncomplicated essential hypertension not satisfactorily controlled by monotherapy, which is candesartan 8 mg or amlodipine 5 mg, were eligible. Candesartan 8 mg and amlodipine 5 mg were given for 12 weeks. 13 patients who received candesartan 8 mg previoursly were assigned to the candesartan group and 8 patients who received amlodipine 5 mg previoursly were assigned to the amlodipine group. Sitting systolic blood pressure (SBP) at baseline was 151.9 ± 11.6 mmHg in the candesartan group, and 154.6 ± 7.6 mmHg in the amlodipine group. Sitting diastolic blood pressure (DBP) was 93.2 ± 13.1 in the candesartan group, and 80.4 ± 14.7 in the amlodipine group. DBP in the amlodipine group was lower than that in the cadesartan group (P = 0.036). After the combination therapy, SBP was significantly reduced in the two groups. DBP showed significant reduction in th

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档